Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 59, Issue 5, 1995, Pages 540-544

  Filippi, Massimo ^a   Campi, Adriana ^a   Martinelli, Vittorio ^a   Colombo, Bruno ^a   Yousry, Tarek ^b   Canal, Nicola ^a   Scotti, Giuseppe ^a   Comi, Giancarlo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Gadolinium DTPA; Magnetic resonance imaging; Primary progressive multiple sclerosis

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; ANALYSIS OF VARIANCE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MULTIPLE SCLEROSIS; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID;

EID: 0028793580     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.59.5.540     Document Type: Review

References (0)